BioCentury | Aug 8, 2020
Translation in Brief

Cocrystal’s COVID-19 antivirals; plus a portable breast cancer diagnostic, Tarveda mini-drug conjugate for solid tumors, and more

...the compound inactive when outside tumor cells. The company, which was founded in 2012 as Blend Therapeutics Inc....
BioCentury | Feb 2, 2017
Financial News

Versant leads Tarveda’s $30M D round

...an extended retention time inside targeted cells, which could increase its efficacy. Formerly known as Blend Therapeutics Inc....
BioCentury | Feb 1, 2016
Finance

Un-Blended

...seen enough data to exclusively focus the cancer company on its biologic-drug conjugates. Tarveda (formerly Blend Therapeutics Inc....
BioCentury | Jan 28, 2016
Financial News

Tarveda raises $38M series C

...Venture Capital also participated. Also on Wednesday, the company changed its name to Tarveda from Blend Therapeutics Inc....
BioCentury | Apr 14, 2015
Company News

Management tracks

...31. Sequeira was VP of Lilly USA at Eli Lilly and Co. (NYSE:LLY). Oncology company Blend Therapeutics Inc....
BioCentury | Jan 26, 2015
Emerging Company Profile

Cloaking conjugates

...its first 18 months using medicinal chemistry to discover novel platinum-based cytotoxic agents for cancer, Blend Therapeutics Inc....
...BTP-114 , is also expected to enter the clinic in mid-2015. Companies and Institutions Mentioned Blend Therapeutics Inc....
...27 (Jan. 12, 2015) Nallanathan, B. "Blend goes platinum." BioCentury 15-16 (Dec. 24, 2012) Sidebars Blend Therapeutics Inc....
BioCentury | Jan 12, 2015
Finance

Blend(ing) a platform

...A fresh capital infusion has provided Blend Therapeutics Inc. the opportunity to develop a platform to optimize the...
BioCentury | Jan 12, 2015
Financial News

Blend Therapeutics financial update

...Blend Therapeutics Inc. , Watertown, Mass. Business: Combinatorial biology, Cancer, Inflammation Date announced: 2015-01-07 Note: Blend Therapeutics...
BioCentury | Jan 8, 2015
Financial News

Cancer play Blend raises $21M

...Cancer company Blend Therapeutics Inc. (Watertown, Mass.) raised $21 million through an undisclosed combination of equity and debt...
BioCentury | Jan 8, 2015
Financial News

Cancer play Blend raises $21M

...Cancer company Blend Therapeutics Inc. (Watertown, Mass.) raised $21 million through an undisclosed combination of equity and debt...
Items per page:
1 - 10 of 21
BioCentury | Aug 8, 2020
Translation in Brief

Cocrystal’s COVID-19 antivirals; plus a portable breast cancer diagnostic, Tarveda mini-drug conjugate for solid tumors, and more

...the compound inactive when outside tumor cells. The company, which was founded in 2012 as Blend Therapeutics Inc....
BioCentury | Feb 2, 2017
Financial News

Versant leads Tarveda’s $30M D round

...an extended retention time inside targeted cells, which could increase its efficacy. Formerly known as Blend Therapeutics Inc....
BioCentury | Feb 1, 2016
Finance

Un-Blended

...seen enough data to exclusively focus the cancer company on its biologic-drug conjugates. Tarveda (formerly Blend Therapeutics Inc....
BioCentury | Jan 28, 2016
Financial News

Tarveda raises $38M series C

...Venture Capital also participated. Also on Wednesday, the company changed its name to Tarveda from Blend Therapeutics Inc....
BioCentury | Apr 14, 2015
Company News

Management tracks

...31. Sequeira was VP of Lilly USA at Eli Lilly and Co. (NYSE:LLY). Oncology company Blend Therapeutics Inc....
BioCentury | Jan 26, 2015
Emerging Company Profile

Cloaking conjugates

...its first 18 months using medicinal chemistry to discover novel platinum-based cytotoxic agents for cancer, Blend Therapeutics Inc....
...BTP-114 , is also expected to enter the clinic in mid-2015. Companies and Institutions Mentioned Blend Therapeutics Inc....
...27 (Jan. 12, 2015) Nallanathan, B. "Blend goes platinum." BioCentury 15-16 (Dec. 24, 2012) Sidebars Blend Therapeutics Inc....
BioCentury | Jan 12, 2015
Finance

Blend(ing) a platform

...A fresh capital infusion has provided Blend Therapeutics Inc. the opportunity to develop a platform to optimize the...
BioCentury | Jan 12, 2015
Financial News

Blend Therapeutics financial update

...Blend Therapeutics Inc. , Watertown, Mass. Business: Combinatorial biology, Cancer, Inflammation Date announced: 2015-01-07 Note: Blend Therapeutics...
BioCentury | Jan 8, 2015
Financial News

Cancer play Blend raises $21M

...Cancer company Blend Therapeutics Inc. (Watertown, Mass.) raised $21 million through an undisclosed combination of equity and debt...
BioCentury | Jan 8, 2015
Financial News

Cancer play Blend raises $21M

...Cancer company Blend Therapeutics Inc. (Watertown, Mass.) raised $21 million through an undisclosed combination of equity and debt...
Items per page:
1 - 10 of 21